E. Ab, E. Ed, A. , and E. , Two important controversial risk factors in SARS-CoV-2 infection: obesity and smoking, 2020.

, Environ. Toxicol. Pharmacol

M. Z. Ahmed, Epidemic of COVID-19 in China and associated psychological problems, Asian J. Psychiatr, vol.51, p.102092, 2020.

G. C. Alexander, An epidemic in the midst of a pandemic: opioid use disorder and COVID-19, Ann. Intern. Med, 2020.

J. S. Alqahtani, Prevalence, severity and mortality associated with COPD and smoking in patients with COVID-19: A rapid systematic review and meta-analysis, PLoS One, vol.15, 2020.

Y. P. Balhara, Effect of lockdown following COVID-19 pandemic on alcohol use and help-seeking behavior: observations and insights from a sample of alcohol use disorder patients under treatment from a tertiary care center, Psychiatry Clin. Neurosci, vol.74, pp.440-441, 2020.

W. C. Becker and D. A. Fiellin, When epidemics collide: coronavirus disease 2019 (COVID-19) and the opioid crisis, Ann. Intern. Med, 2020.

I. Berlin, COVID-19 and smoking, Nicotine Tob. Res, 2020.

M. J. Bohn, The alcohol use disorders identification test (AUDIT): validation of a screening instrument for use in medical settings, J. Stud. Alcohol, vol.56, pp.423-432, 1995.

J. Bommele, The double-edged relationship between COVID-19 stress and smoking: implications for smoking cessation, Tob. Induc. Dis, vol.18, issue.63, 2020.

S. K. Brooks, The psychological impact of quarantine and how to reduce it: rapid review of the evidence, Lancet Lond. Engl, vol.395, issue.20, pp.30460-30468, 2020.

G. Cai, Bulk and single-cell transcriptomics identify tobacco-use disparity in lung gene expression of ACE2, the receptor of 2019-nCov (preprint), Infectious Diseases (Except HIV/AIDS), 2020.

G. Cai, Tobacco smoking increases the lung gene expression of ACE2, the receptor of SARS-CoV-2, Am. J. Respir. Crit. Care Med, 2020.

H. Cai, Sex difference and smoking predisposition in patients with COVID-19, Lancet Respir. Med, vol.8, issue.20, 2020.

, Preliminary estimates of the prevalence of selected underlying health conditions among patients with coronavirus disease 2019 -United States, MMWR Morb. Mortal. Wkly Rep, vol.69, 2020.

J. Changeux, A nicotinic hypothesis for COVID-19 with preventive and therapeutic implications, 2020.
URL : https://hal.archives-ouvertes.fr/hal-02968179

J. Chick, Alcohol and COVID-19, Alcohol Alcohol, 2020.

J. M. Clay and M. O. Parker, Alcohol use and misuse during the COVID-19 pandemic: a potential public health crisis? Lancet Public Health, pp.30088-30096, 2020.

G. Cochran, Medication treatment for opioid use disorder and community pharmacy: expanding care during a national epidemic and global pandemic, Subst. Abus, vol.41, pp.269-274, 2020.

D. Columb, R. Hussain, and C. O'gara, Addiction psychiatry and COVID-19 -impact on patients and service provision, Ir. J. Psychol. Med. 1-15, 2020.

M. Coppola and R. Mondola, Potential pharmacological perspectives for the treatment/prevention of the SARS-COV-2 infection in opioid dependent patients, J. Opioid Manag, vol.16, pp.165-166, 2020.

. Covid-19-lockdown, South Africans are Asking Google How to Make Their Own Alcohol as Booze Ban Bites [WWW Document

B. L. Da, COVID-19 Hangover: A Rising Tide of Alcohol Use Disorder and Alcohol-Associated Liver Disease, Hepatology, 2020.

C. S. Davis and E. A. Samuels, Opioid policy changes during the COVID-19 pandemicand beyond, J. Addict. Med, 2020.

M. C. De-goeij, How economic crises affect alcohol consumption and alcohol-related health problems: a realist systematic review, Soc. Sci. Med, vol.131, pp.131-146, 2015.

R. M. Deacon, Assessing the validity of the Australian treatment outcomes profile for telephone administration in drug health treatment populations, Drug Alcohol Rev, 2020.

M. Delirrad and A. B. Mohammadi, New methanol poisoning outbreaks in Iran following COVID-19 pandemic, Alcohol Alcohol, 2020.

T. M. Dumas, What does adolescent substance use look like during the COVID-19 pandemic? Examining changes in frequency, social contexts, and pandemic-related predictors, J. Adolesc. Health, 2020.

E. J. Edelman, Association of prescribed opioids with increased risk of community-acquired pneumonia among patients with and without HIV, JAMA Intern. Med, vol.179, pp.297-304, 2019.

C. O. Egbe and S. P. Ngobese, COVID-19 lockdown and the tobacco product ban in South Africa, Tob. Induc. Dis, vol.18, issue.39, 2020.

S. Eisenberg and M. J. Eisenberg, Smoking cessation during the COVID-19 epidemic, Nicotine Tob. Res, 2020.

A. Emami, Prevalence of underlying diseases in hospitalized patients with COVID-19: a systematic review and meta-analysis, Arch. Acad. Emerg. Med, vol.8, p.35, 2020.

A. B. Engin, Two important controversial risk factors in SARS-CoV-2 infection: obesity and smoking, Environ. Toxicol. Pharmacol, 2020.

K. Farsalinos, COVID-19 and the nicotinic cholinergic system, Eur. Respir. J, 2020.

K. Farsalinos, Systematic review of the prevalence of current smoking among hospitalized COVID-19 patients in China: could nicotine be a therapeutic option?, Intern. Emerg. Med, 2020.

I. Finlay and I. Gilmore, Covid-19 and alcohol-a dangerous cocktail, BMJ, vol.369, 2020.

S. Galea, The mental health consequences of COVID-19 and physical distancing: the need for prevention and early intervention, JAMA Intern. Med, 2020.

S. Gallus, Who smokes in Europe? Data from 12 European countries in the TackSHS survey (2017-2018), J. Epidemiol, 2020.

A. Gasmi, The global burden of disease attributable to alcohol and drug use in 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study, Alcohol and Drug Use Collaborators, vol.5, issue.18, pp.30337-30344, 2016.

T. V. Giannouchos, Characteristics and risk factors for COVID-19 diagnosis and adverse outcomes in Mexico: an analysis of 89,756 laboratory-confirmed COVID-J. Mallet, et al. Progress in Neuropsychopharmacology & Biological Psychiatry xxx (xxxx) xxxx 19 cases, Eur. Respir. J, 2020.

T. C. Green, Opioid use disorder and the COVID 19 pandemic: A call to sustain regulatory easements and further expand access to treatment, Subst. Abus, vol.41, pp.147-149, 2020.

T. Groshkova, Will the current COVID-19 pandemic impact on long-term Cannabis buying practices?, J. Addict. Med, 2020.

W. Guan, Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis, Eur. Respir. J, pp.547-2020, 2020.

W. Guan, Clinical characteristics of coronavirus disease 2019 in China, N. Engl. J. Med, 2020.

F. R. Guo, Active smoking is associated with severity of coronavirus disease 2019 (COVID-19): an update of a meta-analysis, Tob. Induc. Dis, vol.18, 2020.

A. Håkansson, Changes in gambling behavior during the COVID-19 pandemic-a web survey study in Sweden, Int. J. Environ. Res. Public Health, vol.17, 2020.

A. Håkansson, Gambling during the COVID-19 crisis -a cause for concern?, J. Addict. Med, 2020.

M. Hamer, Lifestyle risk factors, inflammatory mechanisms, and COVID-19 hospitalization: a community-based cohort study of 387,109 adults in UK, Brain Behav. Immun, 2020.

M. Harris, An urgent impetus for action: safe inhalation interventions to reduce COVID-19 transmission and fatality risk among people who smoke crack cocaine in the United Kingdom, Int. J. Drug Policy, 2020.

M. Harris, Low barrier tele-buprenorphine in the time of COVID-19: a case report, J. Addict. Med, 2020.

C. Heerfordt and I. M. Heerfordt, Has there been an increased interest in smoking cessation during the first months of the COVID-19 pandemic? a Google trends study, Public Health, vol.183, pp.6-7, 2020.

R. Heimer, R. Mcneil, and D. Vlahov, A community responds to the COVID-19 pandemic: a case study in protecting the health and human rights of people who use drugs, J. Urban Health Bull. N. Y. Acad. Med, vol.1, issue.9, 2020.

E. Javelle, Electronic cigarette and vaping should be discouraged during the new coronavirus SARS-CoV-2 pandemic, Arch. Toxicol, 2020.

W. D. Jenkins, COVID-19 during the opioid epidemic -exacerbation of stigma and vulnerabilities, J. Rural. Health, 2020.

J. Kaur and A. V. Rinkoo, Public health perspectives of smokeless tobacco and Areca nut use in the COVID-19 era, Nicotine Tob. Res, 2020.

B. Kayhan-tetik, The effect of the COVID-19 pandemic on smoking cessation success, J. Community Health, 2020.

M. E. Killerby, Characteristics associated with hospitalization among patients with COVID-19 -metropolitan, MMWR Morb. Mortal. Wkly Rep, vol.69, pp.790-794, 2020.

O. Király, Preventing problematic internet use during the COVID-19 pandemic: consensus guidance, Compr. Psychiatry, vol.100, p.152180, 2020.

E. M. Klemperer, Change in tobacco and electronic cigarette use and motivation to quit in response to COVID-19, Nicotine Tob. Res, 2020.

S. D. Kowitt, Tobacco quit intentions and Behaviors among cigar smokers in the United States in response to COVID-19, Int. J. Environ. Res. Public Health, vol.17, 2020.

S. Koyama, Determinants of increased tobacco consumption following a major disaster, Disaster Med. Public Health Prep, 2020.

K. Kypri and J. Mccambridge, Alcohol must be recognised as a drug, BMJ, 2018.

H. H. Kyu, Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2017: a systematic analysis for the global burden of disease study 2017, Lancet, vol.392, issue.18, pp.32335-32338, 2018.

J. Q. Lanctot, Effects of disasters on smoking and relapse: an exploratory study of hurricane Katrina victims, Am. J. Health Educ, vol.39, pp.91-94, 2008.

I. E. Leppla and M. S. Gross, Optimizing medication treatment of opioid use disorder during COVID-19 (SARS-CoV-2), J. Addict. Med, 2020.

J. M. Leung and D. D. Sin, Smoking, ACE-2, and COVID-19: ongoing controversies, Eur. Respir. J, 2020.

G. Lippi and B. M. Henry, Active smoking is not associated with severity of coronavirus disease 2019 (COVID-19), Eur. J. Intern. Med, 2020.

G. Lippi, Active smoking and COVID-19: a double-edged sword, Eur. J. Intern. Med, 2020.

E. Lo and B. Lasnier, Active smoking and severity of coronavirus disease 2019 (COVID-19): the use of significance testing leads to an erroneous conclusion, Eur. J. Intern. Med, 2020.

A. Majmundar, Public health concerns and unsubstantiated claims at the intersection of vaping and COVID-19, Nicotine Tob. Res, 2020.

J. Marsden, Mitigating and learning from the impact of COVID-19 infection on addictive disorders, 2020.

C. Mattiuzzi and G. Lippi, Which lessons shall we learn from the 2019 novel coronavirus outbreak?, Ann. Transl. Med, vol.8, p.48, 2020.

J. C. Maxwell, Lessons learned from the deadly sisters: drug and alcohol treatment disruption, and consequences from hurricanes Katrina and Rita, Subst. Use Misuse, vol.44, pp.1681-1694, 2009.

J. Moe and J. A. Buxton, Don't forget our dual public health crises, 2020.

R. Mungmungpuntipantip and V. Wiwanitkit, Sharing alcoholic drinks and a COVID-19 outbreak, Alcohol Alcohol, 2020.

V. L. Narasimha, Complicated alcohol withdrawal-an unintended consequence of COVID-19 lockdown, Alcohol Alcohol, 2020.

Y. Ni, Indoor PM2.5, tobacco smoking and chronic lung diseases: a narrative review, Environ. Res, vol.181, 2020.

F. Okuno, Mild but prolonged elevation of serum angiotensin converting enzyme (ACE) activity in alcoholics, Alcohol Fayettev. N, vol.3, issue.86, pp.90053-90057, 1986.

J. L. Olds and N. Kabbani, Is nicotine exposure linked to cardiopulmonary vulnerability to COVID-19 in the general population? Smoking and COVID19-infection, FEBS J, 2020.

R. Patanavanich and S. A. Glantz, Smoking is associated with COVID-19 progression: a meta-analysis, Nicotine Tob. Res, 2020.

L. E. Pino, Electronic nicotine delivery systems (ECs) and COVID-19: the perfect storm for young consumers, Clin. Transl. Oncol, 2020.

L. M. Plein and H. L. Rittner, Opioids and the immune system -friend or foe, Br. J. Pharmacol, vol.175, pp.2717-2725, 2018.

P. Poloméni and R. Schwan, Management of opioid addiction with buprenorphine: French history and current management, Int. J. Gen. Med, vol.7, pp.143-148, 2014.

R. Polosa and G. Caci, COVID-19: counter-intuitive data on smoking prevalence and therapeutic implications for nicotine, Intern. Emerg. Med. 1-4, 2020.

, Online Alcohol Sales Jump 243% During Coronavirus Pandemic

R. K. Reddy, The effect of smoking on COVID-19 severity: a systematic review and meta-analysis, J. Med. Virol, 2020.

J. Rehm, Alcohol use in times of the COVID 19: implications for monitoring and policy, Drug Alcohol Rev, vol.39, pp.301-304, 2020.

B. Rolland, Global Changes and Factors of Increase in Caloric/Salty Food, Screen, and Substance Use, during the Early COVID-19 Containment Phase in France: A General Population Online Survey, 2020.

S. Roy, Opioid drug abuse and modulation of immune function: consequences in the susceptibility to opportunistic infections, J. NeuroImmune Pharm, vol.6, pp.442-465, 2011.

E. A. Samuels, Innovation during COVID-19: improving addiction treatment access, J. Addict. Med, 2020.

D. D. Satre, Addressing problems with alcohol and other substances among older adults during the COVID-19 pandemic, Am. J. Geriatr. Psychiatry, 2020.

J. Schimmel and A. F. Manini, Opioid use disorder and COVID-19: biological plausibility for worsened outcomes, Subst. Use Misuse, vol.55, 1900.

M. Sexton, Cannabis in the time of coronavirus disease 2019: the Yin and Yang of the endocannabinoid system in immunocompetence, J. Altern. Complement. Med. N. Y. N, vol.26, pp.444-448, 2020.

S. Shekhar and F. Hannah-shmouni, Hookah smoking and COVID-19: call for action, CMAJ Can. Med. Assoc. J, vol.192, 2020.

E. Simou, Alcohol and the risk of pneumonia: a systematic review and metaanalysis, BMJ Open, vol.8, 2018.

S. Slavova, Signal of increased opioid overdose during COVID-19 from emergency medical services data, Drug Alcohol Depend, vol.214, 2020.

R. Soares and C. M. De, Risk factors for hospitalization and mortality due to COVID-19 in Espírito Santo State, Brazil. Am, J. Trop. Med. Hyg, 2020.

L. Sordo, Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies, BMJ, vol.357, 1550.

Y. Sun, Editorial: challenges to opioid use disorders during COVID-19, Am. J. Addict, 2020.

G. Testino and R. Pellicano, Alcohol consumption in the COVID-19 era, Minerva Gastroenterol. Dietol, 2020.

G. Testino, Alcoholic liver disease and the hepatitis C virus: an overview and a point of view, Minerva Med, vol.107, pp.300-313, 2016.

H. A. Tindle, Beyond smoking cessation: investigating medicinal nicotine to prevent and treat COVID-19, Nicotine Tob. Res, 2020.

M. Underner, G. Peiffer, J. Perriot, and N. Jaafari, Tabagisme et maladie à coronavirus 2019 (COVID-19), Rev. Mal. Respir, 2020.

J. Mallet, Progress in Neuropsychopharmacology & Biological Psychiatry xxx (xxxx) xxxx

C. I. Vardavas and K. Nikitara, COVID-19 and smoking: a systematic review of the evidence, Tob. Induc. Dis, vol.18, 1920.

R. P. Varma, Alcohol withdrawal management during the COVID-19 lockdown in Kerala, Indian J. Med. Ethics, vol.V, pp.105-106, 2020.

N. D. Volkow, Collision of the COVID-19 and addiction epidemics, Ann. Intern. Med, 2020.

R. Wang, M. Pan, X. Zhang, X. Fan, M. Han et al., Epidemiological and clinical features of 125 hospitalized patients with COVID-19 in, Int. J. Infect. Dis, 2020.

C. G. Wilson, A primary care response to COVID-19 for patients with an opioid use disorder, J. Rural. Health, 2020.

J. Wong, Short-term preoperative smoking cessation and postoperative complications: a systematic review and meta-analysis, Can. J. Anaesth, vol.59, pp.268-279, 2012.


P. Wu, Alcohol abuse/dependence symptoms among hospital employees exposed to a SARS outbreak, Alcohol Alcohol, vol.43, pp.706-712, 2008.

Q. Zhao, The impact of COPD and smoking history on the severity of COVID-19: a systemic review and meta-analysis, J. Med. Virol, 2020.

W. Zheng, Treatment outcome comparison between telepsychiatry and faceto-face buprenorphine medication-assisted treatment for opioid use disorder: a 2-year retrospective data analysis, J. Addict. Med, vol.11, pp.138-144, 2017.

Z. Zheng, Risk factors of critical & mortal COVID-19 cases: a systematic literature review and meta-analysis, J. Inf. Secur, 2020.